00:00 / 00:00
Mycobacterium is a genus of bacteria that includes many species that are pathogenic to humans. It's known to cause tuberculosis, leprosy, and some non-tuberculosis lung infections. Antimycobacterials are a class of antibiotics effective against mycobacterium species. The primary targets of antimycobacterial drugs are the enzymes that mycobacteria use to build their cell walls. Antimycobacterial drugs are typically administered in combination to target different enzymes and minimize bacterial resistance to these antibiotics.
The first-line antimycobacterials for tuberculosis include rifampin, isoniazid, pyrazinamide, and ethambutol. Second-line antimycobacterials include bedaquiline, cycloserine, ethionamide, rifabutin, aminosalicylic acid, capreomycin, and amikacin. There is also dapsone used to treat leprosy. There may be cases that are multidrug resistant, and these are treated with drugs like bedaquiline, capreomycin, cycloserine, and amikacin.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.